All Stories

  1. An international, multi-center study evaluated rituximab therapy in childhood steroid-resistant nephrotic syndrome
  2. SARS-CoV-2 Humoral Immunity Persists Following Rituximab Therapy
  3. Heterogenous antibody and T‐cell responses to SARS‐CoV‐2 mRNA vaccines among immunocompromised young people
  4. Angiomotin mutation causes glomerulopathy and renal cysts by upregulating hepatocyte nuclear factor transcriptional activity
  5. Long-Term Efficacy and Safety of Repeated Rituximab to Maintain Remission in Idiopathic Childhood Nephrotic Syndrome: An International Study
  6. Multicenter study on the genetics of glomerular diseases among southeast and south Asians: Deciphering Diversities ‐ Renal Asian Genetics Network (DRAGoN)
  7. Zinc and vitamin C intake increases spike and neutralising antibody production following SARS‐CoV‐2 infection
  8. Low regulatory T-cells: A distinct immunological subgroup in minimal change nephrotic syndrome with early relapse following rituximab therapy
  9. IL-13-driven alterations in hepatic cholesterol handling contributes to hypercholesterolemia in a rat model of minimal change disease
  10. Persistent Dengue Infection in an Immunosuppressed Patient Reveals the Roles of Humoral and Cellular Immune Responses in Virus Clearance
  11. MeSsAGe risk score: tool for renal biopsy decision in steroid-dependent nephrotic syndrome
  12. Novel role of Vav1-Rac1 pathway in actin cytoskeleton regulation in Interleukin-13-induced minimal change-like nephropathy
  13. T Lymphocyte Activation Markers as Predictors of Responsiveness to Rituximab among Patients with FSGS